Previous 10 | Next 10 |
Are These The Top Biotech Penny Stocks to Buy in April? The pandemic has shined a large spotlight on biotech penny stocks over the past twelve months. Every time a company announced a new treatment or vaccine for Covid, traders quickly jumped to buy the trend. As a result, many breakout...
HAUPPAUGE, N.Y., April 01, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the commercial launch of an FDA Emergency Use Authorization-approved, in-licensed rapid point-of-car...
Chembio Diagnostics, Inc. (CEMI) Q4 2020 Earnings Conference Call March 11, 2021 4:30 PM ET Company Participants Philip Taylor – Investor Relations Rick Eberly – President and Chief Executive Officer Neil Goldman – Chief Financial Officer Conference Call Participants Kyle...
Chembio Diagnostics (CEMI): Q4 GAAP EPS of -$0.35 misses by $0.07.Revenue of $10.22M (+62.0% Y/Y) beats by $4.45M.Shares -3.4% AH.Press Release For further details see: Chembio Diagnostics EPS misses by $0.07, beats on revenue
HAUPPAUGE, N.Y., March 11, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the quarter and year ended December 31, 2020. Recent Accomplishments & H...
Are These Biotech Penny Stocks On Your Watch List Right Now? The tech wreck continues this week, but that hasn’t put a pause on other sectors. Furthermore, the market’s appetite for risk appears to be growing stronger once again. Earlier today, we saw the list of Reddit ...
HAUPPAUGE, N.Y., March 08, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the appointment of David Bespalko to the Company’s Board of Directors, effective upon his elec...
HAUPPAUGE, N.Y., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the fourth quarter and full year 2020 after the close of tradin...
While there are hopes for widespread vaccinations in the U.S., the pandemic has shown no signs of slowing. Globally, there are now 102.66 million cases. In the U.S., the count is up to 26 million. In India, it’s up to 10.7 million. In Brazil, 9.1 million. In Russia, 3.8 million. In t...
Express (EXPR) +62% as company lines up new financing.DPW Holdings (DPW) +57% as pre-orders for residential level 2 EV chargers have begun on Amazon.Pingtan Marine Enterprise (PME) +43% on announcing FY 2021 guidance.ZW Data Action Technologies (CNET) +38%. after the company wa...
News, Short Squeeze, Breakout and More Instantly...
Chembio Diagnostics Inc. Company Name:
CEMI Stock Symbol:
NASDAQ Market:
Chembio Diagnostics Inc. Website:
Chembio Diagnostics, Inc. becomes the first North American structure controlled by Biosynex in North America STRASBOURG, France, April 27, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of ...
MEDFORD, N.Y., April 19, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 19, 2023 ...
MEDFORD, N.Y., April 10, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 10, 2023 ...